Envestnet Asset Management Inc. Trims Stock Position in Humana Inc. $HUM

Envestnet Asset Management Inc. trimmed its holdings in Humana Inc. (NYSE:HUM) by 19.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 101,302 shares of the insurance provider’s stock after selling 24,382 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.08% of Humana worth $24,766,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Cary Street Partners Investment Advisory LLC lifted its position in shares of Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 46 shares during the last quarter. Zions Bancorporation National Association UT bought a new position in Humana in the first quarter worth about $37,000. CVA Family Office LLC raised its holdings in Humana by 63.4% in the second quarter. CVA Family Office LLC now owns 219 shares of the insurance provider’s stock worth $54,000 after purchasing an additional 85 shares in the last quarter. Ransom Advisory Ltd bought a new position in Humana in the first quarter worth about $66,000. Finally, Transamerica Financial Advisors LLC raised its holdings in Humana by 1,027.6% in the first quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock worth $87,000 after purchasing an additional 298 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on HUM shares. The Goldman Sachs Group started coverage on shares of Humana in a report on Tuesday, October 14th. They set a “sell” rating and a $235.00 price objective on the stock. Guggenheim reiterated a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Truist Financial set a $300.00 price objective on Humana in a research note on Tuesday, October 14th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a research note on Wednesday, October 8th. Finally, Piper Sandler dropped their price objective on shares of Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a research note on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $299.22.

Humana Stock Up 0.7%

NYSE HUM opened at $280.19 on Tuesday. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The company has a quick ratio of 1.95, a current ratio of 1.95 and a debt-to-equity ratio of 0.69. The business’s fifty day simple moving average is $280.99 and its 200-day simple moving average is $258.73. The firm has a market cap of $33.70 billion, a PE ratio of 21.50, a P/E/G ratio of 1.71 and a beta of 0.42.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio (DPR) is 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.